COSCIENS Biopharma Inc. Income Taxes Paid Refund
COSCIENS Biopharma Inc. (CSCIF) reported Income Taxes Paid Refund of -$1.33 million for the 12-month period ending 2023-12-31, per its 20-F/A filed 2024-07-17.
Discontinued › Expense Statement
ifrs-full:IncomeTaxesPaidRefund · last filed 2024-07-17
- COSCIENS Biopharma Inc. income taxes paid refund for the quarter ending 2023-12-31 was -$2.65M.
- COSCIENS Biopharma Inc. income taxes paid refund for the quarter ending 2023-09-30 was $675.00K.
- COSCIENS Biopharma Inc. income taxes paid refund for the quarter ending 2023-06-30 was $647.00K.
- COSCIENS Biopharma Inc. income taxes paid refund for the quarter ending 2022-12-31 was -$1.66M.
| Period end | Income Taxes Paid Refund 3 month | Income Taxes Paid Refund 3 month as first filed | Income Taxes Paid Refund 6 month | Income Taxes Paid Refund 6 month as first filed | Income Taxes Paid Refund 9 month | Income Taxes Paid Refund 9 month as first filed | Income Taxes Paid Refund 12 month | Income Taxes Paid Refund 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | -$2.65M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | -$1.98M derived: sum of 2 quarters · filed 2024-07-17 | -$1.33M derived: sum of 3 quarters · filed 2024-07-17 | -$1.33M 20-F/A · filed 2024-07-17 | ||||
| 2023-09-30 | $675.00K 6-K · filed 2023-11-09 | $1.32M derived: sum of 2 quarters · filed 2023-11-09 | $1.32M 6-K · filed 2023-11-09 | |||||
| 2023-06-30 | $647.00K 6-K · filed 2023-08-09 | $647.00K 6-K · filed 2023-08-09 | ||||||
| 2022-12-31 | -$1.66M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | -$1.66M derived: sum of 2 quarters · filed 2024-07-17 | -$1.71M derived: sum of 3 quarters · filed 2024-07-17 | -$831.00K 20-F/A · filed 2024-07-17 | $831.00K 20-F · filed 2023-03-23 | |||
| 2022-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2023-11-09 | -$51.00K derived: sum of 2 quarters · filed 2023-11-09 | $830.00K 6-K · filed 2023-11-09 | -$830.00K 6-K · filed 2022-11-03 | $368.00K derived: sum of 4 quarters · filed 2024-07-17 | |||
| 2022-06-30 | -$51.00K 6-K · filed 2023-08-09 | $51.00K 6-K/A · filed 2022-08-04 | $830.00K 6-K · filed 2023-08-09 | -$830.00K 6-K/A · filed 2022-08-04 | $368.00K derived: sum of 3 quarters · filed 2024-07-17 | $794.00K derived: sum of 4 quarters · filed 2024-07-17 | ||
| 2022-03-31 | $881.00K 6-K · filed 2023-05-09 | -$881.00K 6-K · filed 2022-05-11 | $419.00K derived: sum of 2 quarters · filed 2024-07-17 | $845.00K derived: sum of 3 quarters · filed 2024-07-17 | $1.36M derived: sum of 4 quarters · filed 2024-07-17 | |||
| 2021-12-31 | -$462.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | -$36.00K derived: sum of 2 quarters · filed 2024-07-17 | $481.00K derived: sum of 3 quarters · filed 2024-07-17 | $1.60M 20-F/A · filed 2024-07-17 | ||||
| 2021-09-30 | $426.00K 6-K · filed 2022-11-03 | $943.00K derived: sum of 2 quarters · filed 2022-11-03 | $2.07M 6-K · filed 2022-11-03 | -$829.00K derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-06-30 | $517.00K 6-K/A · filed 2022-08-04 | $1.64M 6-K/A · filed 2022-08-04 | -$1.25M derived: sum of 3 quarters · filed 2024-02-15 | -$1.25M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-03-31 | $1.12M 6-K · filed 2022-05-11 | -$1.77M derived: sum of 2 quarters · filed 2024-02-15 | -$1.77M derived: sum of 3 quarters · filed 2024-02-15 | -$1.14M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2020-12-31 | -$2.90M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-15 | -$2.90M derived: sum of 2 quarters · filed 2024-02-15 | -$2.26M derived: sum of 3 quarters · filed 2024-02-15 | -$1.45M 20-F/A · filed 2024-02-15 | $1.45M 40-F · filed 2021-03-25 | |||
| 2020-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2021-11-04 | $637.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.45M 6-K · filed 2021-11-04 | |||||
| 2020-06-30 | $637.00K 6-K · filed 2021-08-05 | $1.45M 6-K · filed 2021-08-05 | ||||||
| 2020-03-31 | $811.00K 6-K · filed 2021-05-05 |